Articles from Serenity Medical

Serenity Medical’s River Stent™ Demonstrates Sustained 4- to 5-Year Benefits in Patients with Idiopathic Intracranial Hypertension (IIH), Presented at SNIS Annual Meeting in Late-Breaking Session
Long-term data reinforce durability of venous sinus stenting as an evidence-backed, FDA-approved treatment option
By Serenity Medical · Via GlobeNewswire · July 22, 2026
Serenity Medical Receives U.S. FDA Breakthrough Device Designation for The Serenity Shepherd Stent™ System to Treat Pulsatile Tinnitus
Second FDA Regulatory Milestone for Serenity’s Novel Platform, Following the Recent HDE Approval of the River Stent™ – First Venous Stent for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)
By Serenity Medical · Via GlobeNewswire · June 30, 2026
Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)
Landmark regulatory milestone makes the River stent available for adults with severe IIH – a debilitating, historically undertreated condition – who have failed medical therapy
By Serenity Medical · Via GlobeNewswire · March 31, 2026
Articles from Serenity Medical | MarketMinute